Leon A Flicker,* Samuel D Vasikaran,† Jenny Thomas,‡ John G Acres,§ Paul E Norman,¶ Konrad Jamrozik,** Nicola T Lautenschlager,†† Peter J Leedman,‡‡ Osvaldo P Almeida§§
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 1999; 354: 407-413.
- 2. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002; 346: 476-483.
- 3. Cape RDT, Shinton NK. Serum vitamin B12 concentration in the elderly. Geronontologia Clinica 1961; 3: 163-172.
- 4. Jamrozik K, Norman PE, Spencer CA, et al. Screening for abdominal aortic aneurysm: lessons from a population-based study. Med J Aust 2000; 173: 345-350.
- 5. Seal EC, Metz J, Flicker L, Melny J. A randomised, double blind, placebo controlled study of oral vitamin B12 supplementation in elderly patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc 2002; 50: 146-151.
- 6. Reynolds EH. Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry 2002; 72: 567–571.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
This work was supported by grants from the National Health and Medical Research Council of Australia, and untied research grants from Pfizer CVL, Australian Rotary Health Research Fund and the Australasian Menopause Society. We are grateful to the men and women who participated in this study.